COVID vaccination rates in Canada skyrocket, Moderna deliveries still on hold –

0
16
COVID vaccination rates in Canada skyrocket, Moderna deliveries still on hold – fr


OTTAWA (NEWS 1130) – The Prime Minister congratulates Canadians for rolling up their sleeves, saying our country is advancing in the global ranking of COVID-19 vaccinations. With more and more doses in the arms of Canadians, Prime Minister Justin Trudeau says Canada is now third in the G20 in terms of doses administered per capita.

“More than half of Canadians have now received at least one vaccine against COVID-19. This number will continue to increase rapidly because millions of additional doses are arriving, ”he said.

Canada’s top doctor said ahead of the long weekend in May, the country was seeing a drop in daily COVID cases. She says the latest seven-day average of fewer than 5,000 cases is down from last month.

Dr. Theresa Tam says that to keep the numbers low, everyone should really think about getting the vaccine, in addition to maintaining other transmission prevention measures.

“Masking and spacing… We can keep our progress strong and constant as more vaccine unfolds, to help bring that curve to a landing,” Tam said.

She adds that the number of people with serious and serious illnesses is also falling, and the number of people hospitalized is also down a bit.

However, there are still many questions about vaccine delivery when it comes to Moderna. Trudeau cannot say how many doses we will receive next month, saying only that it will be “millions” and that we are still awaiting a confirmed delivery schedule from the company.

This leaves open the possibility that Canada will fall short of the $ 48 million pledged we expected to receive before Canada Day. Moderna still owes our country at least 6.7 million doses before the end of June.

Moderna said on Tuesday that her trials show her vaccine is safe for children from the age of 12. From his data, the data shows that when the vaccine is used in children 12 to 17 years old, the effectiveness is 93% with a single injection and 100% after the second dose.

Related Articles:

The company studied more than 3,700 young people aged 12 to 17. Preliminary results showed that the vaccine caused the same signs of immune protection in children as in adults, and the same type of temporary side effects such as arm pain, headaches and fatigue.

There was no diagnosis of COVID-19 in people who received two doses of the Moderna vaccine, compared to four cases in children who received placebo injections. In a press release, the company also said the vaccine appeared to be 93% effective two weeks after the first dose.

Moderna recognizes that the numbers could change and that the data still needs to be peer reviewed, but it will make requests to Canada and the United States to expand eligibility.

-With files from The Associated Press



LEAVE A REPLY

Please enter your comment!
Please enter your name here